This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Espinel-Ingroff, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Espinel-Ingroff, A.

 Previous Article  |  Next Article 

Journal of Clinical Microbiology, October 1998, p. 2950-2956, Vol. 36, No. 10
0095-1137/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.

Comparison of In Vitro Activities of the New Triazole SCH56592 and the Echinocandins MK-0991 (L-743,872) and LY303366 against Opportunistic Filamentous and Dimorphic Fungi and Yeasts

Ana Espinel-Ingroff*

Division of Infectious Diseases, Medical College of Virginia, Virginia Commonwealth University, Richmond, Virginia 23298-0049

Received 9 April 1998/Returned for modification 5 June 1998/Accepted 23 June 1998

The in vitro antifungal activities of SCH56592, MK-0991, and LY303366 against 83 isolates of Acremonium strictum, Aspergillus flavus, Aspergillus fumigatus, Aspergillus terreus, Bipolaris spp., Blastomyces dermatitidis, Cladophialophora bantiana, Fusarium oxysporum, Fusarium solani, Histoplasma capsulatum, Phialophora spp., Pseudallescheria boydii, Rhizopus arrhizus, Scedosporium prolificans, and Sporothrix schenckii were compared. The in vitro activities of these agents against 104 isolates of yeast pathogens of Candida spp., Cryptococcus neoformans, and Trichosporon beigelii were also compared. MICs were determined by following a procedure under evaluation by the National Committee for Clinical Laboratory Standards (NCCLS) for broth microdilution testing of the filamentous fungi (visual MICs) and the NCCLS M27-A broth microdilution method for yeasts (both visual and turbidimetric MICs). The in vitro fungicidal activity of SCH56592 was superior (minimum fungicidal concentrations [MFCs], 0.25 to 4 µg/ml for 7 of 18 species tested) to those of MK-0991 and LY303366 (MFCs, 8 to >16 µg/ml for all species tested) for the molds tested, but the echinocandins had a broader spectrum of fungicidal activity (MFCs at which 90% of strains are inhibited [MFC90s], 0.5 to 4 µg/ml for 6 of 9 species tested) than SCH56592 (MFC90s, 0.25 to 8 µg/ml for 4 of 9 species tested) against most of the yeasts tested. Neither echinocandin had in vitro activity (MICs, >16 µg/ml) against C. neoformans and T. beigelii, while the SCH56592 MICs ranged from 0.12 to 1.0 µg/ml for these two species. The MICs of the three agents for the other species ranged from <0.03 to 4 µg/ml. These results suggest that these new agents have broad-spectrum activities in vitro; their effectiveness in the treatment of human mycoses is to be determined.

* Mailing address: Medical College of Virginia of Virginia Commonwealth University, P.O. Box 980049, Richmond, VA 23298-0049. Phone: (804) 828-9711. Fax: (804) 828-3097.

Journal of Clinical Microbiology, October 1998, p. 2950-2956, Vol. 36, No. 10
0095-1137/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.


This article has been cited by other articles:

  • Bommer, M., Hutter, M.-L., Stilgenbauer, S., de Hoog, G. S., de Beer, Z. W., Wellinghausen, N. (2009). Fatal Ophiostoma piceae infection in a patient with acute lymphoblastic leukaemia. J Med Microbiol 58: 381-385 [Abstract] [Full Text]  
  • Morris, M. I. (2009). Posaconazole: A new oral antifungal agent with an expanded spectrum of activity. Am J Health Syst Pharm 66: 225-236 [Abstract] [Full Text]  
  • Maida, C. M., Milici, M. E., Trovato, L., Oliveri, S., Amodio, E., Spreghini, E., Scalise, G., Barchiesi, F. (2008). Evaluation of the Disk Diffusion Method Compared to the Microdilution Method in Susceptibility Testing of Anidulafungin against Filamentous Fungi. J. Clin. Microbiol. 46: 4071-4074 [Abstract] [Full Text]  
  • Rachwalski, E. J, Wieczorkiewicz, J. T, Scheetz, M. H (2008). Posaconazole: An Oral Triazole with an Extended Spectrum of Activity. The Annals of Pharmacotherapy 42: 1429-1438 [Abstract] [Full Text]  
  • Damle, B., Stogniew, M., Dowell, J. (2008). Pharmacokinetics and Tissue Distribution of Anidulafungin in Rats. Antimicrob. Agents Chemother. 52: 2673-2676 [Abstract] [Full Text]  
  • Espinel-Ingroff, A., Canton, E. (2008). Comparison of Neo-Sensitabs Tablet Diffusion Assay with CLSI Broth Microdilution M38-A and Disk Diffusion Methods for Testing Susceptibility of Filamentous Fungi with Amphotericin B, Caspofungin, Itraconazole, Posaconazole, and Voriconazole. J. Clin. Microbiol. 46: 1793-1803 [Abstract] [Full Text]  
  • de la Escalera, C. M., Aller, A. I., Lopez-Oviedo, E., Romero, A., Martos, A. I., Canton, E., Peman, J., Martos, P. G., Martin-Mazuelos, E. (2008). Activity of BAL 4815 against filamentous fungi. J Antimicrob Chemother 61: 1083-1086 [Abstract] [Full Text]  
  • Ibrahim, A. S., Gebremariam, T., Fu, Y., Edwards, J. E. Jr., Spellberg, B. (2008). Combination Echinocandin-Polyene Treatment of Murine Mucormycosis. Antimicrob. Agents Chemother. 52: 1556-1558 [Abstract] [Full Text]  
  • Dannaoui, E., Lortholary, O., Raoux, D., Bougnoux, M. E., Galeazzi, G., Lawrence, C., Moissenet, D., Poilane, I., Hoinard, D., Dromer, F., and the YEASTS Group, (2008). Comparative In Vitro Activities of Caspofungin and Micafungin, Determined Using the Method of the European Committee on Antimicrobial Susceptibility Testing, against Yeast Isolates Obtained in France in 2005-2006. Antimicrob. Agents Chemother. 52: 778-781 [Abstract] [Full Text]  
  • Cortez, K. J., Roilides, E., Quiroz-Telles, F., Meletiadis, J., Antachopoulos, C., Knudsen, T., Buchanan, W., Milanovich, J., Sutton, D. A., Fothergill, A., Rinaldi, M. G., Shea, Y. R., Zaoutis, T., Kottilil, S., Walsh, T. J. (2008). Infections Caused by Scedosporium spp.. Clin. Microbiol. Rev. 21: 157-197 [Abstract] [Full Text]  
  • Antachopoulos, C., Meletiadis, J., Sein, T., Roilides, E., Walsh, T. J. (2008). Comparative In Vitro Pharmacodynamics of Caspofungin, Micafungin, and Anidulafungin against Germinated and Nongerminated Aspergillus Conidia. Antimicrob. Agents Chemother. 52: 321-328 [Abstract] [Full Text]  
  • Canton, E., Peman, J., Espinel-Ingroff, A., Martin-Mazuelos, E., Carrillo-Munoz, A., Martinez, J. P. (2008). Comparison of disc diffusion assay with the CLSI reference method (M27-A2) for testing in vitro posaconazole activity against common and uncommon yeasts. J Antimicrob Chemother 61: 135-138 [Abstract] [Full Text]  
  • Ullmann, A. J., Krammes, E., Sommer, S., Buschmann, I., Jahn-Muehl, B., Cacciapuoti, A., Schmitt, H.-J. (2007). Efficacy of posaconazole and amphotericin B in experimental invasive pulmonary aspergillosis in dexamethasone immunosuppressed rats. J Antimicrob Chemother 60: 1080-1084 [Abstract] [Full Text]  
  • Soczo, G., Kardos, G., McNicholas, P. M., Balogh, E., Gergely, L., Varga, I., Kelentey, B., Majoros, L. (2007). Correlation of posaconazole minimum fungicidal concentration and time kill test against nine Candida species. J Antimicrob Chemother 60: 1004-1009 [Abstract] [Full Text]  
  • Armstrong-James, D. (2007). Invasive Candida species infection: the importance of adequate empirical antifungal therapy. J Antimicrob Chemother 60: 459-460 [Abstract] [Full Text]  
  • Fuchs, B. B., Tegos, G. P., Hamblin, M. R., Mylonakis, E. (2007). Susceptibility of Cryptococcus neoformans to Photodynamic Inactivation Is Associated with Cell Wall Integrity. Antimicrob. Agents Chemother. 51: 2929-2936 [Abstract] [Full Text]  
  • Wiederhold, N. P., Najvar, L. K., Bocanegra, R., Molina, D., Olivo, M., Graybill, J. R. (2007). In Vivo Efficacy of Anidulafungin and Caspofungin against Candida glabrata and Association with In Vitro Potency in the Presence of Sera. Antimicrob. Agents Chemother. 51: 1616-1620 [Abstract] [Full Text]  
  • Schwarz, P., Lortholary, O., Dromer, F., Dannaoui, E. (2007). Carbon Assimilation Profiles as a Tool for Identification of Zygomycetes. J. Clin. Microbiol. 45: 1433-1439 [Abstract] [Full Text]  
  • Krishna, G., Sansone-Parsons, A., Martinho, M., Kantesaria, B., Pedicone, L. (2007). Posaconazole Plasma Concentrations in Juvenile Patients with Invasive Fungal Infection. Antimicrob. Agents Chemother. 51: 812-818 [Abstract] [Full Text]  
  • Dowell, J. A., Stogniew, M., Krause, D., Henkel, T., Damle, B. (2007). Lack of Pharmacokinetic Interaction Between Anidulafungin and Tacrolimus. J Clin Pharmacol 47: 305-314 [Abstract] [Full Text]  
  • Ullmann, A. J., Lipton, J. H., Vesole, D. H., Chandrasekar, P., Langston, A., Tarantolo, S. R., Greinix, H., Morais de Azevedo, W., Reddy, V., Boparai, N., Pedicone, L., Patino, H., Durrant, S. (2007). Posaconazole or Fluconazole for Prophylaxis in Severe Graft-versus-Host Disease. NEJM 356: 335-347 [Abstract] [Full Text]  
  • Kauffman, C. A. (2007). Histoplasmosis: a Clinical and Laboratory Update. Clin. Microbiol. Rev. 20: 115-132 [Abstract] [Full Text]  
  • Li, J., Xu, Y.-C., Bai, F.-Y. (2006). Candida pseudorugosa sp. nov., a Novel Yeast Species from Sputum. J. Clin. Microbiol. 44: 4486-4490 [Abstract] [Full Text]  
  • Spellberg, B., Schwartz, J., Fu, Y., Avanesian, V., Adler-Moore, J., Edwards, J. E. Jr, Ibrahim, A. S. (2006). Comparison of antifungal treatments for murine fusariosis. J Antimicrob Chemother 58: 973-979 [Abstract] [Full Text]  
  • Cota, J., Carden, M., Graybill, J. R., Najvar, L. K., Burgess, D. S., Wiederhold, N. P. (2006). In Vitro Pharmacodynamics of Anidulafungin and Caspofungin against Candida glabrata Isolates, Including Strains with Decreased Caspofungin Susceptibility. Antimicrob. Agents Chemother. 50: 3926-3928 [Abstract] [Full Text]  
  • Espinel-Ingroff, A. (2006). Comparison of Three Commercial Assays and a Modified Disk Diffusion Assay with Two Broth Microdilution Reference Assays for Testing Zygomycetes, Aspergillus spp., Candida spp., and Cryptococcus neoformans with Posaconazole and Amphotericin B. J. Clin. Microbiol. 44: 3616-3622 [Abstract] [Full Text]  
  • Canton, E., Peman, J., Sastre, M., Romero, M., Espinel-Ingroff, A. (2006). Killing Kinetics of Caspofungin, Micafungin, and Amphotericin B against Candida guilliermondii.. Antimicrob. Agents Chemother. 50: 2829-2832 [Abstract] [Full Text]  
  • Katiyar, S., Pfaller, M., Edlind, T. (2006). Candida albicans and Candida glabrata Clinical Isolates Exhibiting Reduced Echinocandin Susceptibility.. Antimicrob. Agents Chemother. 50: 2892-2894 [Abstract] [Full Text]  
  • McLellan, G. J., Aquino, S. M., Mason, D. R., Kinyon, J. M., Myers, R. K. (2006). Use of Posaconazole in the Management of Invasive Orbital Aspergillosis in a Cat. Journal of the American Animal Hospital Association 42: 302-307 [Abstract] [Full Text]  
  • Ha, Y.-s., Covert, S. F., Momany, M. (2006). FsFKS1, the 1,3-{beta}-Glucan Synthase from the Caspofungin-Resistant Fungus Fusarium solani.. Eukaryot Cell 5: 1036-1042 [Abstract] [Full Text]  
  • Gubbins, P. O., Krishna, G., Sansone-Parsons, A., Penzak, S. R., Dong, L., Martinho, M., Anaissie, E. J. (2006). Pharmacokinetics and safety of oral posaconazole in neutropenic stem cell transplant recipients.. Antimicrob. Agents Chemother. 50: 1993-1999 [Abstract] [Full Text]  
  • Sansone-Parsons, A., Krishna, G., Calzetta, A., Wexler, D., Kantesaria, B., Rosenberg, M. A., Saltzman, M. A. (2006). Effect of a Nutritional Supplement on Posaconazole Pharmacokinetics following Oral Administration to Healthy Volunteers.. Antimicrob. Agents Chemother. 50: 1881-1883 [Abstract] [Full Text]  
  • Lopez-Oviedo, E., Aller, A. I., Martin, C., Castro, C., Ramirez, M., Peman, J. M., Canton, E., Almeida, C., Martin-Mazuelos, E. (2006). Evaluation of Disk Diffusion Method for Determining Posaconazole Susceptibility of Filamentous Fungi: Comparison with CLSI Broth Microdilution Method. Antimicrob. Agents Chemother. 50: 1108-1111 [Abstract] [Full Text]  
  • Benjamin, D. K. Jr., Driscoll, T., Seibel, N. L., Gonzalez, C. E., Roden, M. M., Kilaru, R., Clark, K., Dowell, J. A., Schranz, J., Walsh, T. J. (2006). Safety and Pharmacokinetics of Intravenous Anidulafungin in Children with Neutropenia at High Risk for Invasive Fungal Infections. Antimicrob. Agents Chemother. 50: 632-638 [Abstract] [Full Text]  
  • Schwarz, P., Bretagne, S., Gantier, J.-C., Garcia-Hermoso, D., Lortholary, O., Dromer, F., Dannaoui, E. (2006). Molecular Identification of Zygomycetes from Culture and Experimentally Infected Tissues. J. Clin. Microbiol. 44: 340-349 [Abstract] [Full Text]  
  • Mattiuzzi, G. N., Alvarado, G., Giles, F. J., Ostrosky-Zeichner, L., Cortes, J., O'Brien, S., Verstovsek, S., Faderl, S., Zhou, X., Raad, I. I., Bekele, B. N., Leitz, G. J., Lopez-Roman, I., Estey, E. H. (2006). Open-Label, Randomized Comparison of Itraconazole versus Caspofungin for Prophylaxis in Patients with Hematologic Malignancies. Antimicrob. Agents Chemother. 50: 143-147 [Abstract] [Full Text]  
  • Barchiesi, F., Spreghini, E., Tomassetti, S., Arzeni, D., Giannini, D., Scalise, G. (2005). Comparison of the Fungicidal Activities of Caspofungin and Amphotericin B against Candida glabrata. Antimicrob. Agents Chemother. 49: 4989-4992 [Abstract] [Full Text]  
  • Pfaller, M. A., Diekema, D. J., Boyken, L., Messer, S. A., Tendolkar, S., Hollis, R. J., Goldstein, B. P. (2005). Effectiveness of Anidulafungin in Eradicating Candida Species in Invasive Candidiasis. Antimicrob. Agents Chemother. 49: 4795-4797 [Abstract] [Full Text]  
  • Pitisuttithum, P., Negroni, R., Graybill, J. R., Bustamante, B., Pappas, P., Chapman, S., Hare, R. S., Hardalo, C. J. (2005). Activity of posaconazole in the treatment of central nervous system fungal infections. J Antimicrob Chemother 56: 745-755 [Abstract] [Full Text]  
  • Spellberg, B., Edwards, J. Jr., Ibrahim, A. (2005). Novel Perspectives on Mucormycosis: Pathophysiology, Presentation, and Management. Clin. Microbiol. Rev. 18: 556-569 [Abstract] [Full Text]  
  • Canton, E., Peman, J., Gobernado, M., Alvarez, E., Baquero, F., Cisterna, R., Gil, J., Martin-Mazuelos, E., Rubio, C., Sanchez-Sousa, A., Serrano, C. (2005). Sensititre YeastOne Caspofungin Susceptibility Testing of Candida Clinical Isolates: Correlation with Results of NCCLS M27-A2 Multicenter Study. Antimicrob. Agents Chemother. 49: 1604-1607 [Abstract] [Full Text]  
  • Girmenia, C., Pagano, L., Martino, B., D'Antonio, D., Fanci, R., Specchia, G., Melillo, L., Buelli, M., Pizzarelli, G., Venditti, M., Martino, P., the GIMEMA Infection Program, (2005). Invasive Infections Caused by Trichosporon Species and Geotrichum capitatum in Patients with Hematological Malignancies: a Retrospective Multicenter Study from Italy and Review of the Literature. J. Clin. Microbiol. 43: 1818-1828 [Abstract] [Full Text]  
  • Carrillo-Munoz, A.-J., Quindos, G., Ruesga, M., Alonso, R., del Valle, O., Hernandez-Molina, J. M., McNicholas, P., Loebenberg, D., Santos, P. (2005). Antifungal activity of posaconazole compared with fluconazole and amphotericin B against yeasts from oropharyngeal candidiasis and other infections. J Antimicrob Chemother 55: 317-319 [Abstract] [Full Text]  
  • Dowell, J. A., Stogniew, M., Krause, D., Henkel, T., Weston, I. E. (2005). Assessment of the Safety and Pharmacokinetics of Anidulafungin When Administered With Cyclosporine. J Clin Pharmacol 45: 227-233 [Abstract] [Full Text]  
  • Diekema, D. J., Petroelje, B., Messer, S. A., Hollis, R. J., Pfaller, M. A (2005). Activities of Available and Investigational Antifungal Agents against Rhodotorula Species. J. Clin. Microbiol. 43: 476-478 [Abstract] [Full Text]  
  • Simitsopoulou, M., Gil-Lamaignere, C., Avramidis, N., Maloukou, A., Lekkas, S., Havlova, E., Kourounaki, L., Loebenberg, D., Roilides, E. (2004). Antifungal Activities of Posaconazole and Granulocyte-Macrophage Colony-Stimulating Factor Ex Vivo and in Mice with Disseminated Infection Due to Scedosporium prolificans. Antimicrob. Agents Chemother. 48: 3801-3805 [Abstract] [Full Text]  
  • Imai, J. K., Singh, G., Clemons, K. V., Stevens, D. A. (2004). Efficacy of Posaconazole in a Murine Model of Central Nervous System Aspergillosis. Antimicrob. Agents Chemother. 48: 4063-4066 [Abstract] [Full Text]  
  • Pfaller, M. A., Diekema, D. J. (2004). Rare and Emerging Opportunistic Fungal Pathogens: Concern for Resistance beyond Candida albicans and Aspergillus fumigatus. J. Clin. Microbiol. 42: 4419-4431 [Full Text]  
  • Steinbach, W. J., Perfect, J. R., Schell, W. A., Walsh, T. J., Benjamin, D. K. Jr. (2004). In Vitro Analyses, Animal Models, and 60 Clinical Cases of Invasive Aspergillus terreus Infection. Antimicrob. Agents Chemother. 48: 3217-3225 [Full Text]  
  • Odds, F. C., Motyl, M., Andrade, R., Bille, J., Canton, E., Cuenca-Estrella, M., Davidson, A., Durussel, C., Ellis, D., Foraker, E., Fothergill, A. W., Ghannoum, M. A., Giacobbe, R. A., Gobernado, M., Handke, R., Laverdiere, M., Lee-Yang, W., Merz, W. G., Ostrosky-Zeichner, L., Peman, J., Perea, S., Perfect, J. R., Pfaller, M. A., Proia, L., Rex, J. H., Rinaldi, M. G., Rodriguez-Tudela, J.-L., Schell, W. A., Shields, C., Sutton, D. A., Verweij, P. E., Warnock, D. W. (2004). Interlaboratory Comparison of Results of Susceptibility Testing with Caspofungin against Candida and Aspergillus Species. J. Clin. Microbiol. 42: 3475-3482 [Abstract] [Full Text]  
  • Odabasi, Z., Paetznick, V. L., Rodriguez, J. R., Chen, E., Ostrosky-Zeichner, L. (2004). In Vitro Activity of Anidulafungin against Selected Clinically Important Mold Isolates. Antimicrob. Agents Chemother. 48: 1912-1915 [Abstract] [Full Text]  
  • Espinel-Ingroff, A., Pfaller, M., Messer, S. A., Knapp, C. C., Holliday, N., Killian, S. B. (2004). Multicenter Comparison of the Sensititre YeastOne Colorimetric Antifungal Panel with the NCCLS M27-A2 Reference Method for Testing New Antifungal Agents against Clinical Isolates of Candida spp.. J. Clin. Microbiol. 42: 718-721 [Abstract] [Full Text]  
  • Madariaga, M. G., Tenorio, A., Proia, L. (2003). Trichosporon inkin Peritonitis Treated with Caspofungin. J. Clin. Microbiol. 41: 5827-5829 [Abstract] [Full Text]  
  • Zaas, A. K., Boyce, M., Schell, W., Lodge, B. A., Miller, J. L., Perfect, J. R. (2003). Risk of Fungemia Due to Rhodotorula and Antifungal Susceptibility Testing of Rhodotorula Isolates. J. Clin. Microbiol. 41: 5233-5235 [Abstract] [Full Text]  
  • Serrano, M. C., Morilla, D., Valverde, A., Chavez, M., Espinel-Ingroff, A., Claro, R., Ramirez, M., Mazuelos, E. M. (2003). Comparison of Etest with Modified Broth Microdilution Method for Testing Susceptibility of Aspergillus spp. to Voriconazole. J. Clin. Microbiol. 41: 5270-5272 [Abstract] [Full Text]  
  • Marty, F. M., Barouch, D. H., Coakley, E. P., Baden, L. R. (2003). Disseminated Trichosporonosis Caused by Trichosporon loubieri. J. Clin. Microbiol. 41: 5317-5320 [Abstract] [Full Text]  
  • Serena, C., Ortoneda, M., Capilla, J., Pastor, F. J., Sutton, D. A., Rinaldi, M. G., Guarro, J. (2003). In Vitro Activities of New Antifungal Agents against Chaetomium spp. and Inoculum Standardization. Antimicrob. Agents Chemother. 47: 3161-3164 [Abstract] [Full Text]  
  • Courtney, R., Pai, S., Laughlin, M., Lim, J., Batra, V. (2003). Pharmacokinetics, Safety, and Tolerability of Oral Posaconazole Administered in Single and Multiple Doses in Healthy Adults. Antimicrob. Agents Chemother. 47: 2788-2795 [Abstract] [Full Text]  
  • Martin-Mazuelos, E., Peman, J., Valverde, A., Chaves, M., Serrano, M. C., Canton, E. (2003). Comparison of the Sensititre YeastOne colorimetric antifungal panel and Etest with the NCCLS M38-A method to determine the activity of amphotericin B and itraconazole against clinical isolates of Aspergillus spp.. J Antimicrob Chemother 52: 365-370 [Abstract] [Full Text]  
  • Diekema, D. J., Messer, S. A., Hollis, R. J., Jones, R. N., Pfaller, M. A. (2003). Activities of Caspofungin, Itraconazole, Posaconazole, Ravuconazole, Voriconazole, and Amphotericin B against 448 Recent Clinical Isolates of Filamentous Fungi. J. Clin. Microbiol. 41: 3623-3626 [Abstract] [Full Text]  
  • Steinbach, W. J., Schell, W. A., Miller, J. L., Perfect, J. R. (2003). Scedosporium prolificans Osteomyelitis in an Immunocompetent Child Treated with Voriconazole and Caspofungin, as Well as Locally Applied Polyhexamethylene Biguanide. J. Clin. Microbiol. 41: 3981-3985 [Abstract] [Full Text]  
  • Bartizal, C., Odds, F. C. (2003). Influences of Methodological Variables on Susceptibility Testing of Caspofungin against Candida Species and Aspergillus fumigatus. Antimicrob. Agents Chemother. 47: 2100-2107 [Abstract] [Full Text]  
  • Novicki, T. J., LaFe, K., Bui, L., Bui, U., Geise, R., Marr, K., Cookson, B. T. (2003). Genetic Diversity among Clinical Isolates of Acremonium strictum Determined during an Investigation of a Fatal Mycosis. J. Clin. Microbiol. 41: 2623-2628 [Abstract] [Full Text]  
  • Nakai, T., Uno, J., Ikeda, F., Tawara, S., Nishimura, K., Miyaji, M. (2003). In Vitro Antifungal Activity of Micafungin (FK463) against Dimorphic Fungi: Comparison of Yeast-Like and Mycelial Forms. Antimicrob. Agents Chemother. 47: 1376-1381 [Abstract] [Full Text]  
  • Pfaller, M. A., Diekema, D. J., Messer, S. A., Hollis, R. J., Jones, R. N. (2003). In Vitro Activities of Caspofungin Compared with Those of Fluconazole and Itraconazole against 3,959 Clinical Isolates of Candida spp., Including 157 Fluconazole-Resistant Isolates. Antimicrob. Agents Chemother. 47: 1068-1071 [Abstract] [Full Text]  
  • Letscher-Bru, V., Herbrecht, R. (2003). Caspofungin: the first representative of a new antifungal class. J Antimicrob Chemother 51: 513-521 [Abstract] [Full Text]  
  • Espinel-Ingroff, A. (2003). Evaluation of Broth Microdilution Testing Parameters and Agar Diffusion Etest Procedure for Testing Susceptibilities of Aspergillus spp. to Caspofungin Acetate (MK-0991). J. Clin. Microbiol. 41: 403-409 [Abstract] [Full Text]  
  • Dannaoui, E., Meletiadis, J., Mouton, J. W., Meis, J. F. G. M., Verweij, P. E., the Eurofung Network, (2003). In vitro susceptibilities of zygomycetes to conventional and new antifungals. J Antimicrob Chemother 51: 45-52 [Abstract] [Full Text]  
  • Arevalo, M. P., Carrillo-Munoz, A.-J., Salgado, J., Cardenes, D., Brio, S., Quindos, G., Espinel-Ingroff, A. (2003). Antifungal activity of the echinocandin anidulafungin (VER002, LY-303366) against yeast pathogens: a comparative study with M27-A microdilution method. J Antimicrob Chemother 51: 163-166 [Abstract] [Full Text]  
  • Pacetti, S. A, Gelone, S. P (2003). Caspofungin Acetate for Treatment of Invasive Fungal Infections. The Annals of Pharmacotherapy 37: 90-98 [Abstract] [Full Text]  
  • Espinel-Ingroff, A., Chaturvedi, V., Fothergill, A., Rinaldi, M. G. (2002). Optimal Testing Conditions for Determining MICs and Minimum Fungicidal Concentrations of New and Established Antifungal Agents for Uncommon Molds: NCCLS Collaborative Study. J. Clin. Microbiol. 40: 3776-3781 [Abstract] [Full Text]  
  • Chryssanthou, E., Cuenca-Estrella, M. (2002). Comparison of the Antifungal Susceptibility Testing Subcommittee of the European Committee on Antibiotic Susceptibility Testing Proposed Standard and the E-Test with the NCCLS Broth Microdilution Method for Voriconazole and Caspofungin Susceptibility Testing of Yeast Species. J. Clin. Microbiol. 40: 3841-3844 [Abstract] [Full Text]  
  • Bowman, J. C., Hicks, P. S., Kurtz, M. B., Rosen, H., Schmatz, D. M., Liberator, P. A., Douglas, C. M. (2002). The Antifungal Echinocandin Caspofungin Acetate Kills Growing Cells of Aspergillus fumigatus In Vitro. Antimicrob. Agents Chemother. 46: 3001-3012 [Abstract] [Full Text]  
  • Perea, S., Gonzalez, G., Fothergill, A. W., Kirkpatrick, W. R., Rinaldi, M. G., Patterson, T. F. (2002). In Vitro Interaction of Caspofungin Acetate with Voriconazole against Clinical Isolates of Aspergillus spp.. Antimicrob. Agents Chemother. 46: 3039-3041 [Abstract] [Full Text]  
  • Ripeau, J.-S., Aumont, F., Belhumeur, P., Ostrosky-Zeichner, L., Rex, J. H., de Repentigny, L. (2002). Effect of the Echinocandin Caspofungin on Expression of Candida albicans Secretory Aspartyl Proteinases and Phospholipase In Vitro. Antimicrob. Agents Chemother. 46: 3096-3100 [Abstract] [Full Text]  
  • Espinel-Ingroff, A., Fothergill, A., Peter, J., Rinaldi, M. G., Walsh, T. J. (2002). Testing Conditions for Determination of Minimum Fungicidal Concentrations of New and Established Antifungal Agents for Aspergillus spp.: NCCLS Collaborative Study. J. Clin. Microbiol. 40: 3204-3208 [Abstract] [Full Text]  
  • Kirkpatrick, W. R., Perea, S., Coco, B. J., Patterson, T. F. (2002). Efficacy of Caspofungin Alone and in Combination with Voriconazole in a Guinea Pig Model of Invasive Aspergillosis. Antimicrob. Agents Chemother. 46: 2564-2568 [Abstract] [Full Text]  
  • Ortoneda, M., Capilla, J., Pastor, F. J., Pujol, I., Guarro, J. (2002). Efficacy of Liposomal Amphotericin B in Treatment of Systemic Murine Fusariosis. Antimicrob. Agents Chemother. 46: 2273-2275 [Abstract] [Full Text]  
  • Sun, Q. N., Najvar, L. K., Bocanegra, R., Loebenberg, D., Graybill, J. R. (2002). In Vivo Activity of Posaconazole against Mucor spp. in an Immunosuppressed-Mouse Model. Antimicrob. Agents Chemother. 46: 2310-2312 [Abstract] [Full Text]  
  • Denning, D. W. (2002). Echinocandins: a new class of antifungal. J Antimicrob Chemother 49: 889-891 [Full Text]  
  • Espinel-Ingroff, A., Rezusta, A. (2002). E-Test Method for Testing Susceptibilities of Aspergillus spp. to the New Triazoles Voriconazole and Posaconazole and to Established Antifungal Agents: Comparison with NCCLS Broth Microdilution Method. J. Clin. Microbiol. 40: 2101-2107 [Abstract] [Full Text]  
  • Pfaller, M. A., Messer, S. A., Hollis, R. J., Jones, R. N. (2002). Antifungal Activities of Posaconazole, Ravuconazole, and Voriconazole Compared to Those of Itraconazole and Amphotericin B against 239 Clinical Isolates of Aspergillus spp. and Other Filamentous Fungi: Report from SENTRY Antimicrobial Surveillance Program, 2000. Antimicrob. Agents Chemother. 46: 1032-1037 [Abstract] [Full Text]  
  • Paphitou, N. I., Ostrosky-Zeichner, L., Paetznick, V. L., Rodriguez, J. R., Chen, E., Rex, J. H. (2002). In Vitro Antifungal Susceptibilities of Trichosporon Species. Antimicrob. Agents Chemother. 46: 1144-1146 [Abstract] [Full Text]  
  • Petraitiene, R., Petraitis, V., Groll, A. H., Sein, T., Schaufele, R. L., Francesconi, A., Bacher, J., Avila, N. A., Walsh, T. J. (2002). Antifungal Efficacy of Caspofungin (MK-0991) in Experimental Pulmonary Aspergillosis in Persistently Neutropenic Rabbits: Pharmacokinetics, Drug Disposition, and Relationship to Galactomannan Antigenemia. Antimicrob. Agents Chemother. 46: 12-23 [Abstract] [Full Text]  
  • Chakinala, M. M., Kollef, M. H., Trulock, E. P. (2002). Critical Care Aspects of Lung Transplant Patients. J Intensive Care Med 17: 8-33 [Abstract]  
  • Pfaller, M. A., Messer, S. A., Mills, K., Bolmstrom, A., Jones, R. N. (2001). Evaluation of Etest Method for Determining Posaconazole MICs for 314 Clinical Isolates of Candida Species. J. Clin. Microbiol. 39: 3952-3954 [Abstract] [Full Text]  
  • Rex, J. H., Pfaller, M. A., Walsh, T. J., Chaturvedi, V., Espinel-Ingroff, A., Ghannoum, M. A., Gosey, L. L., Odds, F. C., Rinaldi, M. G., Sheehan, D. J., Warnock, D. W. (2001). Antifungal Susceptibility Testing: Practical Aspects and Current Challenges. Clin. Microbiol. Rev. 14: 643-658 [Abstract] [Full Text]  
  • Pfaller, M. A., Messer, S. A., Hollis, R. J., Jones, R. N. (2001). In Vitro Activities of Posaconazole (Sch 56592) Compared with Those of Itraconazole and Fluconazole against 3,685 Clinical Isolates of Candida spp. and Cryptococcus neoformans. Antimicrob. Agents Chemother. 45: 2862-2864 [Abstract] [Full Text]  
  • Espinel-Ingroff, A., Bartlett, M., Chaturvedi, V., Ghannoum, M., Hazen, K. C., Pfaller, M. A., Rinaldi, M., Walsh, T. J. (2001). Optimal Susceptibility Testing Conditions for Detection of Azole Resistance in Aspergillus spp.: NCCLS Collaborative Evaluation. Antimicrob. Agents Chemother. 45: 1828-1835 [Abstract] [Full Text]  
  • Petraitiene, R., Petraitis, V., Groll, A. H., Sein, T., Piscitelli, S., Candelario, M., Field-Ridley, A., Avila, N., Bacher, J., Walsh, T. J. (2001). Antifungal Activity and Pharmacokinetics of Posaconazole (SCH 56592) in Treatment and Prevention of Experimental Invasive Pulmonary Aspergillosis: Correlation with Galactomannan Antigenemia. Antimicrob. Agents Chemother. 45: 857-869 [Abstract] [Full Text]  
  • Espinel-Ingroff, A. (2001). In Vitro Fungicidal Activities of Voriconazole, Itraconazole, and Amphotericin B against Opportunistic Moniliaceous and Dematiaceous Fungi. J. Clin. Microbiol. 39: 954-958 [Abstract] [Full Text]  
  • Groll, A. H., Gullick, B. M., Petraitiene, R., Petraitis, V., Candelario, M., Piscitelli, S. C., Walsh, T. J. (2001). Compartmental Pharmacokinetics of the Antifungal Echinocandin Caspofungin (MK-0991) in Rabbits. Antimicrob. Agents Chemother. 45: 596-600 [Abstract] [Full Text]  
  • Espinel-Ingroff, A. (2001). Germinated and Nongerminated Conidial Suspensions for Testing of Susceptibilities of Aspergillus spp. to Amphotericin B, Itraconazole, Posaconazole, Ravuconazole, and Voriconazole. Antimicrob. Agents Chemother. 45: 605-607 [Abstract] [Full Text]  
  • Arikan, S., Lozano-Chiu, M., Paetznick, V., Rex, J. H. (2001). In Vitro Susceptibility Testing Methods for Caspofungin against Aspergillus and Fusarium Isolates. Antimicrob. Agents Chemother. 45: 327-330 [Abstract] [Full Text]  
  • Reichenberger, F., Habicht, J.M., Gratwohl, A., Tamm, M. (2001). Diagnosis and treatment of invasive pulmonary aspergillosis in neutropenic patients. Eur Respir J 19: 743-755 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»